Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation M Frick, W Chan, CM Arends, R Hablesreiter, A Halik, M Heuser, ... Journal of Clinical Oncology 37 (5), 375-385, 2019 | 223 | 2019 |
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis CM Arends, J Galan-Sousa, K Hoyer, W Chan, M Jäger, K Yoshida, ... Leukemia 32 (9), 1908-1919, 2018 | 194 | 2018 |
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma L Mansouri, D Noerenberg, E Young, E Mylonas, M Abdulla, M Frick, ... Blood, The Journal of the American Society of Hematology 128 (23), 2666-2670, 2016 | 105 | 2016 |
D7‐brane moduli space in axion monodromy and fluxbrane inflation M Arends, A Hebecker, K Heimpel, S Kraus, D Luest, C Mayrhofer, ... Fortschritte der Physik 62 (8), 647-702, 2014 | 83 | 2014 |
Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis CM Arends, M Weiss, F Christen, C Eulenberg-Gustavus, A Rousselle, ... Haematologica 105 (6), e264, 2020 | 78 | 2020 |
Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke CM Arends, TG Liman, PM Strzelecka, A Kufner, P Löwe, S Huo, CM Stein, ... Blood 141 (7), 787-799, 2023 | 60 | 2023 |
Clonal hematopoiesis is associated with improved survival in patients with metastatic colorectal cancer from the FIRE-3 trial CM Arends, S Dimitriou, A Stahler, R Hablesreiter, PM Strzelecka, ... Blood, The Journal of the American Society of Hematology 139 (10), 1593-1597, 2022 | 39 | 2022 |
Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti‐CD19 CAR T‐cell Treated Patients V Panagiota, JF Kerschbaum, O Penack, CM Stein, CM Arends, ... Hemasphere 7 (10), e957, 2023 | 29 | 2023 |
Refining AML treatment: the role of genetics in response and resistance evaluation to new agents A Halik, CM Arends, L Bullinger, F Damm, M Frick Cancers 14 (7), 1689, 2022 | 10 | 2022 |
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer CM Arends, K Kopp, R Hablesreiter, N Estrada, F Christen, UM Moll, ... Leukemia 38 (6), 1378-1389, 2024 | 7 | 2024 |
Clonal hematopoiesis of indeterminate potential-related epigenetic age acceleration correlates with clonal hematopoiesis of indeterminate potential clone size in patients with … JD Feldkamp, VM Vetter, CM Arends, TJL Lang, L Bullinger, F Damm, ... Haematologica 107 (7), 1703, 2022 | 7 | 2022 |
CHIP-related epigenetic age acceleration correlates with CHIP clone size in patients with high morbidity JD Feldkamp, VM Vetter, CM Arends, TJL Lang, L Bullinger, F Damm, ... Haematologica 107 (7), 1703-1708, 2022 | 3 | 2022 |
Clonal hematopoiesis: Cell of origin, lineage repartition and dynamic evolution during chemotherapy M Frick, CM Arends, J Galan-Sousa, K Hoyer, W Chan, M Jäger, ... Blood 130, 632, 2017 | 3 | 2017 |
Clonal hematopoiesis is common in unrelated stem cell donors but has no impact on patient outcome after hematopoietic stem cell transplantation J Schetelig, F Damm, UP Günther, H Baldauf, C Rave, L Koster, G Schöfl, ... Blood 142 (Supplement 1), 942-942, 2023 | 2 | 2023 |
Dynamics of clonal hematopoiesis and risk of hematologic malignancy CM Arends, S Jaiswal International Journal of Hematology, 1-9, 2024 | 1 | 2024 |
Klonale Hämatopoese und solide Neoplasien CM Arends, F Damm Wiener klinisches Magazin 26 (1), 16-23, 2023 | 1 | 2023 |
047. CLONAL HEMATOPOIESIS IN PATIENTS WITH ANCA-ASSCOCIATED VASCULITIS C Arends, M Weiss, C Eulenberg-Gustavus, A Rousselle, R Kettritz, ... Rheumatology 58 (Supplement_2), kez057. 046, 2019 | 1 | 2019 |
Gene-Specific Machine Learning Models to Classify Driver Mutations in Clonal Hematopoiesis CM Arends, S Jaiswal Cancer Discovery 14 (9), 1581-1583, 2024 | | 2024 |
Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer CM Arends, K Kopp, R Hablesreiter, N Estrada, F Christen, UM Moll, ... Leukemia 38 (6), 1440, 2024 | | 2024 |
Clonal Hematopoiesis in Whole-Blood and Cell-Free DNA of Ovarian Cancer Patients Undergoing PARP-Inhibitor Treatment: An Exploratory Analysis of the ENGOT-ov48/Eudario Trial CM Arends, K Kopp, N Estrada-Barreras, R Hablesreiter, N Concin, ... Blood 142, 1317, 2023 | | 2023 |